Amgen Inc (AMGN)
319.22
-0.94
(-0.29%)
USD |
NASDAQ |
Nov 01, 16:00
317.56
-1.66
(-0.52%)
After-Hours: 20:00
Amgen Price to Book Value: 22.80 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 22.80 |
| October 31, 2024 | 22.86 |
| October 30, 2024 | 22.53 |
| October 29, 2024 | 22.57 |
| October 28, 2024 | 22.65 |
| October 25, 2024 | 22.64 |
| October 24, 2024 | 22.54 |
| October 23, 2024 | 22.49 |
| October 22, 2024 | 22.83 |
| October 21, 2024 | 22.62 |
| October 18, 2024 | 22.97 |
| October 17, 2024 | 22.95 |
| October 16, 2024 | 22.97 |
| October 15, 2024 | 23.21 |
| October 14, 2024 | 23.18 |
| October 11, 2024 | 23.45 |
| October 10, 2024 | 22.92 |
| October 09, 2024 | 23.02 |
| October 08, 2024 | 22.69 |
| October 07, 2024 | 22.67 |
| October 04, 2024 | 22.83 |
| October 03, 2024 | 22.67 |
| October 02, 2024 | 22.83 |
| October 01, 2024 | 22.87 |
| September 30, 2024 | 23.01 |
| Date | Value |
|---|---|
| September 27, 2024 | 29.26 |
| September 26, 2024 | 28.94 |
| September 25, 2024 | 28.37 |
| September 24, 2024 | 30.01 |
| September 23, 2024 | 30.44 |
| September 20, 2024 | 30.60 |
| September 19, 2024 | 30.47 |
| September 18, 2024 | 30.19 |
| September 17, 2024 | 30.18 |
| September 16, 2024 | 30.40 |
| September 13, 2024 | 30.15 |
| September 12, 2024 | 29.93 |
| September 11, 2024 | 29.93 |
| September 10, 2024 | 29.83 |
| September 09, 2024 | 29.56 |
| September 06, 2024 | 29.07 |
| September 05, 2024 | 29.42 |
| September 04, 2024 | 29.99 |
| September 03, 2024 | 29.97 |
| August 30, 2024 | 30.27 |
| August 29, 2024 | 30.02 |
| August 28, 2024 | 29.88 |
| August 27, 2024 | 29.65 |
| August 26, 2024 | 29.64 |
| August 23, 2024 | 29.82 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
11.11
Minimum
Mar 12 2020
149.73
Maximum
May 31 2022
28.31
Average
18.83
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 5.495 |
| Eli Lilly and Co | 54.59 |
| Merck & Co Inc | 5.926 |
| Regeneron Pharmaceuticals Inc | 3.161 |
| Viking Therapeutics Inc | 8.910 |
Price to Book Value Related Metrics
| PE Ratio | 40.87 |
| PS Ratio | 5.291 |
| Price to Free Cash Flow | 27.40 |
| Price | 319.22 |
| Earnings Yield | 2.45% |
| Market Cap | 171.59B |
| Operating PE Ratio | 27.68 |
| Normalized PE Ratio | 40.87 |